Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Cash from Investing Activities (2021 - 2025)

Biote (BTMD) has 5 years of Cash from Investing Activities data on record, last reported at -$690000.0 in Q3 2025.

  • For Q3 2025, Cash from Investing Activities rose 65.05% year-over-year to -$690000.0; the TTM value through Sep 2025 reached -$5.8 million, down 485.09%, while the annual FY2024 figure was -$18.8 million, 592.89% down from the prior year.
  • Cash from Investing Activities reached -$690000.0 in Q3 2025 per BTMD's latest filing, up from -$2.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $316.1 million in Q2 2021 and bottomed at -$317.5 million in Q1 2021.
  • Average Cash from Investing Activities over 5 years is -$1.7 million, with a median of -$1.0 million recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 6208.04% in 2023, then plummeted 3104.21% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$1.0 million in 2021, then surged by 70.3% to -$311000.0 in 2022, then surged by 6208.04% to $19.0 million in 2023, then plummeted by 106.9% to -$1.3 million in 2024, then surged by 47.37% to -$690000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$690000.0 in Q3 2025, -$2.0 million in Q2 2025, and -$1.8 million in Q1 2025.